Prevalence and risk factors for Atrial Fibrillation and quality of anti coagulation treatment in the medical ward Objectives

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-associated renal dysfunction and injury

  2006cited by this paper
• Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate; effect on plasma prolactin level

  2004influential reference
• Dopamine Agonist Therapy for Hyperprolactinemia

  2003influential reference
• Diagnosis and management of hyperprolactinemia.

  2003influential reference
• Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

  2002influential reference
• Hyperprolactinemia: Etiology, Diagnosis, and Management

  2002influential reference
• Remifentanil, propofol or both for conscious sedation during eye surgery under regional anaesthesia.

  1999cited by this paper
• Pathogenetic mechanisms in nephrotoxic acute renal failure.

  1997cited by this paper
• Hyperprolactinemia in postmenopausal women.

  1997influential reference
• Mortality and morbidity associated with ophthalmic surgery.

  1995cited by this paper
• Progress in the management of hyperprolactinemia.

  1994influential reference
• Inhibition of gonadotropin hormone-releasing hormone release by prolactin from GT1 neuronal cell lines through prolactin receptors.

  1994influential reference
• Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.

  1994cited by this paper
• Long-term cardiac prognosis following noncardiac surgery

  1992cited by this paper
• Dopamine agonists and pituitary tumor shrinkage.

  1992influential reference
• A new local anesthesia technique for cataract extraction by one quadrant sub-Tenon's infiltration.

  1992cited by this paper
• A comparison of propofol, midazolam, and methohexital for sedation during retrobulbar and peribulbar block.

  1992cited by this paper
• [Treatment of fibrocystic breast disease with lisuride].

  1991influential reference
• Laparoscopic cholecystectomy: historic perspective and personal experience.

  1991cited by this paper
• [Treatment of the hyperprolactinemic states with lisuride in a simple open study].

  1991cited by this paper
• Laparoscopic laser cholecystectomy: analysis of 500 procedures.

  1991cited by this paper
• The European experience with laparoscopic cholecystectomy.

  1991cited by this paper
• Perioperative cardiac morbidity

  1990cited by this paper
• The efficacy of lisuride in the treatment of hyperprolactinemic amenorrhea.

  1990influential reference
• A critical review of visual analogue scales in the measurement of clinical phenomena.

  1990cited by this paper
• Association of Perioperative Myocardial Ischemia with Cardiac Morbidity and Mortality in Men Undergoing Noncardiac Surgery

  1990cited by this paper
• Ocular anesthesia for cataract surgery: a direct sub-Tenon's approach.

  1990cited by this paper
• [Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome].

  1989cited by this paper
• Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea.

  1986influential reference
• The efficacy of bromocriptine in patients with ovulatory dysfunction and normoprolactinemic galactorrhea.

  1985influential reference
• Psychotic reactions during treatment of pituitary tumours with dopamine agonists.

  1984cited by this paper
• Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.

  1984influential reference
• Decreased bone density in hyperprolactinemic women.

  1981influential reference
• Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's disease.

  1980influential reference
• Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders.

  1979influential reference
• EFFECT OF LISURIDE ON INHIBITION OF LACTATION AND SERUM PROLACTIN

  1979influential reference
• Metabolic clearance and production rates of prolactin in man.

  1979influential reference
• THE EFFECT OF LISURIDE HYDROGEN MALEATE IN THE HYPERPROLACTINAEMIA‐AMENORRHOEA SYNDROME: CLINICAL AND HORMONAL RESPONSES

  1978cited by this paper
• Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

  1977influential reference

• No citing papers are available for this paper.